New supplement aims to ease menopause-related body changes in midlife women
NCT ID NCT07615777
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a 12-week nutritional supplement (containing myo-inositol, berberine, cinnamon, and chromium) can improve body composition and menopause symptoms in 80 women aged 38-55 who are experiencing irregular periods or related symptoms. Participants will take capsules daily and attend two visits for blood, urine, and body measurements. The results will be compared to a placebo group.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BODY COMPOSITION CHANGES are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
NIHR Southampton Clinical Research Facility
Southampton, Hampshire, SO16 6YD, United Kingdom
Contact Phone: •••-•••-•••• Email: •••••@•••••